Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy

<div>The<i> in vitro</i> cytotoxicity of (a) DOX<svg height="4.3561pt" id="M36" style="vertical-align:-0.04981995pt" version="1.1" viewbox="-0.0498162 -4.30628 3.20019 4.3561" width="3.20019pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M170 255C170 288 146 313 114 313S58 288 58 255C58 221 82 198 114 198S170 221 170 255Z" id="g113-46"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="228" vert-adv-y="228"></glyph.data></g></svg>HCl, DOX-CHGC, DOX-PCP-CHGC, and (b) CHGC and PCP-CHGC micelles against LNCaP cells after 24-hour incubation.</div>

Journal of Nanomaterials

fig9

Figure 9

Figure 9: Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy 